A critical assessment of vector control for dengue prevention
- PMID: 25951103
- PMCID: PMC4423954
- DOI: 10.1371/journal.pntd.0003655
A critical assessment of vector control for dengue prevention
Abstract
Recently, the Vaccines to Vaccinate (v2V) initiative was reconfigured into the Partnership for Dengue Control (PDC), a multi-sponsored and independent initiative. This redirection is consistent with the growing consensus among the dengue-prevention community that no single intervention will be sufficient to control dengue disease. The PDC's expectation is that when an effective dengue virus (DENV) vaccine is commercially available, the public health community will continue to rely on vector control because the two strategies complement and enhance one another. Although the concept of integrated intervention for dengue prevention is gaining increasingly broader acceptance, to date, no consensus has been reached regarding the details of how and what combination of approaches can be most effectively implemented to manage disease. To fill that gap, the PDC proposed a three step process: (1) a critical assessment of current vector control tools and those under development, (2) outlining a research agenda for determining, in a definitive way, what existing tools work best, and (3) determining how to combine the best vector control options, which have systematically been defined in this process, with DENV vaccines. To address the first step, the PDC convened a meeting of international experts during November 2013 in Washington, DC, to critically assess existing vector control interventions and tools under development. This report summarizes those deliberations.
Conflict of interest statement
The authors have declared that no competing interests exist.
Figures
References
-
- World Health Organization. Sustaining the drive to overcome the global impact of neglected tropical diseases: Second WHO report on neglected diseases. Geneva: World Health Organization;2013. http://www.who.int/iris/handle/10665/77950.
-
- World Health Organization; Dengue guidelines for diagnosis, treatment, prevention and control. Geneva: World Health Organization;2009. http://www.who.int/iris/handle/10665/44188. - PubMed
-
- Gunther VJ, Putnak R, Eckels KH, Mammen MP, Scherer JM, Lyons A, et al. A human challenge model for dengue infection reveals a possible protective role for sustained interferon gamma levels during the acute phase of illness. Vaccine. 2011; 29(22): 3895–3904. 10.1016/j.vaccine.2011年03月03日8 - DOI - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous